COL11A1 has also been found to be expressed at the front of invasive carcinomas by presumably carcinoma cells, putatively undergoing epithelial-to-mesenchymal (EMT) transition; also, carcinoma-derived cells with highly metastatic capabilities can express COL11A165. The gene discussed is COL11A1; the disease is invasive carcinoma.